9
Computer programs relating to assays for the diagnosis of diseases; computer programs which utilize data from a patient specimen assay and compare it to values which are considered to be normal, and computer programs for automatically performing all or a portion of the disease diagnostic process; computer programs relating to chemical markers for diseases states; computer programs for monitoring several disease states using two or more chemical markers in each assay and for comparing the concentration of each marker with a database; computer programs for performing diagnostics for diseases by analyzing the results of an assay and providing an indication of possible disease states; computer programs relating to determining targets for drugs, computer programs for inspecting and analyzing databases of biological processes and predicting potential drug targets; computer programs relating to determining protein and peptide sequences; computer programs for accepting analysis results and for determining therefrom which biological substances are present and the structure of such biological substances; scientific instruments for developing assays for the diagnosis of diseases; scientific instruments for developing chemical markers for disease states; scientific instruments for performing diagnostics for diseases; scientific instruments for developing assays for the diagnosis of diseases; scientific instruments for determining targets for drugs; scientific instruments for determining protein and peptide sequences; mass spectrometers, sample separation apparatus, sample enrichment apparatus, sample preparation apparatus, optical detectors, and micro-fluidic sample processing apparatus
42
Medical research; developing assays for the diagnosis of diseases; developing chemical markers which indicate the presence of disease states; performing diagnostics for diseases; analysing and reporting on patient specimens; determining biological targets for drugs; determining biological processes which are susceptible to being affected by drugs, in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets, and for developing sequencing databases; developing methodologies relating to the foregoing services; developing bioanalytical methods to increase the throughput of the identification and characetrization of biological substances such as proteins used as biomarkers for a diagnosis or as drug targets; developing biochemistry processes and instrumentation for said foregoing services; developing simplified methods of performing said foregoing services; developing methods to reduce the sample sizes needed, and to increase the reliability of assays; leasing of mass spectrometers, electrophoresis analyzers, separation apparatus, liquid chromatographs, capillary electrophoresis apparatus and optical detection systems; leasing of ultraviolet, fluorescence and chemiluminescent detectors, microfluid apparatus, and sample preparation apparatus
44
Leasing of medical equipment